Lumosa Therapeutics Co., Ltd. (6535.TWO)
TWD 144.0
(-10.0%)
TWD 144.0
(-10.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -238.04 Million TWD | 51.88% |
| 2022 | -494.66 Million TWD | -615.56% |
| 2021 | 95.94 Million TWD | 129.74% |
| 2020 | -322.56 Million TWD | -33.88% |
| 2019 | -240.93 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -115.61 Million TWD | -2.77% |
| 2024 Q2 | 67.32 Million TWD | 158.23% |
| 2023 Q2 | -150.95 Million TWD | -203.86% |
| 2023 Q4 | -112.5 Million TWD | 6.18% |
| 2023 FY | -238.04 Million TWD | 51.88% |
| 2023 Q1 | 145.33 Million TWD | 266.66% |
| 2023 Q3 | -119.91 Million TWD | 20.56% |
| 2022 Q3 | -154.65 Million TWD | 0.0% |
| 2022 FY | -494.66 Million TWD | -615.56% |
| 2022 Q4 | 39.63 Million TWD | 125.63% |
| 2021 FY | 95.94 Million TWD | 129.74% |
| 2020 FY | -322.56 Million TWD | -33.88% |
| 2019 FY | -240.93 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 194.832% |
| Level Biotechnology Inc. | 62.9 Million TWD | 478.413% |
| Sagittarius Life Science Corp | -55.03 Million TWD | -332.495% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | -268.228% |
| TaiMed Biologics Inc. | -194.81 Million TWD | -22.191% |
| GlycoNex Incorporation | -178.36 Million TWD | -33.459% |
| VBI | -6.6 Million TWD | -3506.135% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | -43.165% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | -2128.431% |
| Visgeneer Inc. | -19.58 Million TWD | -1115.177% |
| Mycenax Biotech Inc. | -682.84 Million TWD | 65.14% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 138.043% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 428.786% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 79.476% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | -3836.514% |
| Enimmune corporation | -223.74 Million TWD | -6.39% |
| TaiRx, Inc. | -212.29 Million TWD | -12.129% |
| CHO Pharma, Inc. | -306.08 Million TWD | 22.231% |
| EirGenix Inc. | -915.2 Million TWD | 73.991% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 578.542% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | -275.933% |
| Lin BioScience, Inc. | -687.19 Million TWD | 65.36% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | -52.273% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | 1144.406% |
| Bio Preventive Medicine Corp. | -73.28 Million TWD | -224.815% |
| Lukas Biomedical Inc. | -47.35 Million TWD | -402.695% |
| RBC Bioscience Corporation | 6.43 Million TWD | 3802.037% |
| BiOptic Inc. | 37.74 Million TWD | 730.622% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | 65.402% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | -540.498% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | -286.807% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 186.615% |
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | -359.698% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | -523.601% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | -41.635% |
| Neith Corporation | -40.03 Million TWD | -494.612% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | -158.431% |
| NaviFUS Corp. | -65.72 Million TWD | -262.155% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | -170.228% |
| Sinew Pharma Inc. | -170.92 Million TWD | -39.27% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | -249.244% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 282.178% |
| AP Biosciences Inc | -339.29 Million TWD | 29.842% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | 57.591% |
| 3D Global Biotech Inc. | -57.95 Million TWD | -310.763% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | 2915.054% |
| Intech Biopharm Corporation | -337.98 Million TWD | 29.571% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 81.869% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | -361.204% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | -39.464% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 144.131% |
| TCI GENE Inc. | 11.67 Million TWD | 2139.244% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | -86.629% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | 19.664% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | -9.438% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 2452.184% |
| PharmaEngine, Inc. | 274.65 Million TWD | 186.671% |
| Savior Lifetec Corporation | 30.03 Million TWD | 892.677% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 274.094% |
| OBI Pharma, Inc. | -1.04 Billion TWD | 77.253% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | -89.907% |
| Acepodia, Inc. | -817.31 Million TWD | 70.875% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 51.267% |